Hamidreza Mohammadi | Neuropharmacology | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Hamidreza Mohammadi
Affiliation Mazandaran University of Medical science
Country Iran
Scopus ID 56962768300
Documents 1264
Citations 1370
h-index 24
Subject Area Neuropharmacology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-7053-6850

Hamidreza Mohammadi is affiliated with Mazandaran University of Medical science, Iran, and has contributed to the fields of neuropharmacology, toxicology, oxidative stress research, mitochondrial dysfunction, and nanoparticle-mediated therapeutic development. His research profile reflects interdisciplinary investigations associated with pharmacological toxicology, mitochondrial protection, neuroprotective strategies, and oxidative injury mechanisms in experimental models.[1] His academic contributions include studies related to paraquat-induced neurotoxicity, nanoparticle therapeutics, oxidative stress biomarkers, and toxicological evaluation methodologies that are relevant to modern pharmaceutical and biomedical sciences.[2]

Abstract

The Innovative Research Award recognition highlights the scientific activities and academic contributions of Hamidreza Mohammadi in pharmaceutical toxicology and neuropharmacological sciences. His investigations include oxidative stress modulation, mitochondrial dysfunction analysis, paraquat-induced toxicity, nanoparticle-assisted therapeutic systems, and pharmacological interventions associated with cellular injury mechanisms. Published studies demonstrate collaborative research focused on toxicological pathways, mitochondrial protection, neuroprotective therapies, and nanomedicine-based pharmaceutical applications.[2] These scholarly activities have contributed to the advancement of experimental toxicology and translational pharmaceutical sciences in both preclinical and applied biomedical contexts.

Keywords

Neuropharmacology, Toxicology, Oxidative Stress, Mitochondrial Dysfunction, Paraquat Toxicity, Nanomedicine, Pharmaceutical Sciences, Experimental Pharmacology, Toxicological Research, Therapeutic Nanoparticles.

Introduction

Modern pharmaceutical sciences increasingly emphasize translational research approaches that integrate neuropharmacology, toxicology, nanotechnology, and mitochondrial medicine. Within this scientific environment, Hamidreza Mohammadi has participated in research investigating toxicant-induced cellular injury, neuroprotective mechanisms, oxidative stress pathways, and nanoparticle-assisted drug delivery systems. Several of his studies examine the biological consequences of paraquat exposure, mitochondrial dysfunction, and pharmacological interventions that may reduce oxidative injury in experimental models.[3] These investigations contribute to broader pharmaceutical discussions concerning therapeutic safety, oxidative balance, neurotoxicity prevention, and innovative biomedical strategies.

Research Profile

Hamidreza Mohammadi is associated with Mazandaran University of Medical Sciences and maintains an active academic profile in neuropharmacology and toxicological sciences.[1] His publication record includes collaborative investigations involving mitochondrial protection, toxicant-induced oxidative stress, neuroprotective therapeutics, nanoparticle systems, and pharmacological interventions targeting cellular dysfunction. His Scopus profile reports a substantial scholarly output and citation presence that reflects ongoing scientific engagement in pharmaceutical and biomedical research fields.[1]

Research Contributions

The scientific contributions of Hamidreza Mohammadi include studies focused on paraquat-induced neurotoxicity, oxidative mitochondrial injury, toxicological risk mechanisms, and nanoparticle-assisted therapeutic systems. Research publications have explored mitochondrial oxidative damage, antiemetic neuroprotection, toxicological evaluation of chemicals, and pharmacological mitigation of oxidative injury.[2] Additional work has examined the application of quercetin-loaded nanoparticles, curcumin formulations, and magnesium-based nanocarriers in experimental toxicology models.[4] These contributions collectively support scientific understanding of toxicant-induced physiological disruption and therapeutic intervention strategies.

Publications

Selected publications associated with Hamidreza Mohammadi include research articles in journals related to toxicology, pharmaceutical sciences, oxidative stress biology, and neuropharmacology. His studies investigate paraquat toxicity, mitochondrial dysfunction, nanoparticle therapeutics, and toxicological pharmacology using experimental models and translational biomedical approaches.[2]

Research Impact

The research activities of Hamidreza Mohammadi demonstrate interdisciplinary relevance across pharmaceutical toxicology, neuropharmacology, nanomedicine, and mitochondrial biology. His scholarly output contributes to scientific understanding of oxidative stress-mediated toxicity and therapeutic mitigation strategies. Research findings associated with nanoparticle formulations, mitochondrial protection, and toxicological pharmacology may support future investigations into safer pharmaceutical interventions and experimental therapeutic systems.[5] Citation metrics and publication activity further indicate continued engagement with internationally indexed pharmaceutical research platforms.

Award Suitability

The Innovative Research Award category is aligned with scholarly activities involving emerging pharmaceutical methodologies, toxicological innovation, and interdisciplinary biomedical research. Hamidreza Mohammadi’s work in oxidative stress mechanisms, neuroprotective pharmacology, toxicological assessment, and nanoparticle-based therapeutics reflects research themes commonly associated with contemporary pharmaceutical innovation.[3] His contributions demonstrate relevance to translational pharmaceutical sciences and experimental therapeutic development within academic and biomedical research communities.

Conclusion

Hamidreza Mohammadi has contributed to pharmaceutical and biomedical sciences through research activities centered on neuropharmacology, toxicology, oxidative stress, mitochondrial dysfunction, and nanomedicine. His publication profile reflects continued academic engagement in experimental toxicology and therapeutic investigation. The Innovative Research Award recognition acknowledges these scholarly contributions and their relevance to advancing pharmaceutical research methodologies and translational biomedical understanding.

References

  1. Elsevier. (n.d.). Scopus author details: Hamidreza Mohammadi, Author ID 56962768300. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56962768300
  2. Jahani, R., Pourbahram, P., Seyedabadi, M., Nasiri, F., & Mohammadi, H. (2025). The role of GABAergic receptors in acute, subacute, and withdrawal syndrome on pain and seizure thresholds in mice: A connection to mitochondrial function and oxidative stress in the brain. Toxicology Reports.DOI: https://pubmed.ncbi.nlm.nih.gov/41312119/
  3. Sadeghi, S., Karami, M., Madanchi, H., Yazdian-Robati, R., Seyedabadi, M., Ghasempouri, S. K., Siahposht-Khachaki, A., & Mohammadi, H. (2025). Microfluidic techniques in the development of PLGA nanoparticles: a tri-combination therapy for paraquat-induced cytotoxicity. Toxicology Research.DOI: https://doi.org/10.1093/toxres/tfaf133
  4. Khederzadeh, A., Ebrahimnejad, P., Seyedabadi, M., Babaei, A., Talebpour Amiri, F., Aslani, N., Mojarad-Jabali, S., & Mohammadi, H. (2024). Synergistic effect of curcumin and Piperine loaded Niosomal nanoparticles on acute pulmonary toxicity induced by Paraquat in mice. Toxicology Research.DOI: https://doi.org/10.1093/toxres/tfae181
  5. Ashari, S., Karami, M., Shokrzadeh, M., Bagheri, A., Ghandadi, M., Ranaee, M., Dashti, A., & Mohammadi, H. (2022). Quercetin ameliorates Di (2-ethylhexyl) phthalate-induced nephrotoxicity by inhibiting NF-κB signaling pathway. Toxicology Research.DOI: https://doi.org/10.1093/toxres/tfac006

Mahnaz Bayat | Neuropharmacology | Research Excellence Award

Published on by Top Pharmaceutical

Dr. Mahnaz Bayat | Neuropharmacology | Research Excellence Award

clinical neurology research center | Iran

Dr. Mahnaz Bayat is a dedicated and research-driven academic with extensive expertise spanning both experimental and clinical dimensions of neurological disorders. She currently serves as an Assistant Professor at the Clinical Neurology Research Center, where her work integrates translational neuroscience with patient-oriented clinical research. Dr. Bayat has substantial hands-on experience in clinical trials and advanced neurological investigations, with a particular emphasis on bridging laboratory discoveries and clinical application. Her scientific expertise includes disease modeling across a broad spectrum of neurological conditions, as well as sophisticated electrophysiological recording techniques that enable in-depth analysis of neural function and dysfunction. In parallel with her research activities, she is deeply engaged in graduate and postgraduate education, serving as a thesis advisor for neurology residents and supervising multiple Master’s and doctoral students in the basic medical sciences. Her academic teaching portfolio encompasses physiology education for students across medicine, dentistry, and pharmacy, reflecting her strong interdisciplinary foundation. Dr. Bayat has established a solid publication record in peer-reviewed scientific journals and is recognized for her meaningful contributions to collaborative and interdisciplinary research initiatives. Her primary research interests include electrophysiology, clinical neurology, neurodegenerative diseases, neurological biomarkers, and translational neuroscience, with a growing focus on improving diagnostic precision and therapeutic strategies. Through her combined roles as a clinician-scientist, educator, and researcher, Dr. Bayat continues to advance neurological science while contributing to the development of future clinicians and researchers in the field.

Citation Metrics (Scopus)

600

450

300

150

0

Citations
581

Documents
50

h-index
15

Citations
Documents
h-index


View Scopus Profile View Google Scholar Profile

Featured Publications

Rebeca Perez | Neuropharmacology | Young Scientist Award

Published on by Top Pharmaceutical

Dr. Rebeca Perez | Neuropharmacology | Young Scientist Award

Universidad de la Frontera | Chile

Dr. Rebeca Perez is a highly accomplished pharmaceutical chemist whose academic and professional career is distinguished by an integrated approach to pharmaceutical chemistry, molecular biology, and applied pharmacology. With advanced doctoral training and extensive university teaching experience, her work is centered on understanding and combating neurodegenerative disorders through innovative, multidisciplinary research. Her scientific focus lies particularly in the study of bioactive natural products and their neuroprotective potential, framed within a strong territorial and environmental perspective that values regional biodiversity and translational relevance.Dr. Perez has developed and managed sophisticated in vitro experimental platforms, including immortalized cell lines and primary neuronal cultures, to investigate the cellular and molecular mechanisms underlying neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. Her expertise spans a wide range of advanced laboratory techniques, including Western blotting, DNA and RNA extraction, molecular sequencing, and immunohistochemistry. These tools enable her to explore signaling pathways, protein expression profiles, and molecular targets involved in neuronal damage and neuroprotection, contributing to the identification of promising therapeutic candidates.Beyond cellular models, her research vision extends toward the integration of experimental animal models with future translational and patient-oriented studies, aiming to bridge the gap between bench research and clinical application. This forward-looking approach reflects her commitment to developing innovative and effective therapeutic strategies for neurodegenerative diseases, an area of critical global health importance.Dr. Perez is also recognized for her strong collaborative profile, maintaining active international scientific partnerships with leading researchers in neuropharmacology and neuroscience, as well as robust national and emerging international collaborations. These partnerships enhance the scientific depth and global relevance of her work, fostering interdisciplinary dialogue and shared innovation across institutions and countries.In parallel with her research endeavors, Dr. Perez has built a solid academic teaching career in chemistry and pharmacy education. She has delivered both theoretical and laboratory-based courses across undergraduate programs, covering areas such as scientific research methodology, project formulation, organic chemistry, biochemistry, pharmaceutical technology, and pharmaceutical chemical analysis. Her teaching philosophy emphasizes critical thinking, scientific rigor, and the integration of research into professional training, preparing students to meet contemporary challenges in pharmaceutical sciences.

Citation Metrics (Scopus)

200

150

100

50

0

Citations
147

Documents
9

h-index
5


View Scopus Profile
 View Google Scholar Profile

Featured Publications

Slawomir Michalak | Neuropharmacology | Top Pharmaceutical Breakthrough Award

Published on by Top Pharmaceutical

Prof. Slawomir Michalak | Neuropharmacology | Top Pharmaceutical Breakthrough Award

Institute of Neurological Disorders Poznan University of Medical Sciences | Poland

Prof. Slawomir Michalak is an accomplished neurologist, neuropathologist, and laboratory medicine specialist whose contributions have significantly advanced clinical neuroscience, translational neurology, and biomarker-driven research. He leads the Stroke Unit at the University Hospital in Poznań while simultaneously heading the Department of Neurology, the Department of Neurosurgery, and the Institute of Neurological Disorders at Poznan University of Medical Sciences. His academic journey includes prestigious international fellowships at the Biochemisches Institut of Christian Albrechts Universität in Kiel and at the Istituto di Patologia Generale of the Università degli Studi in Perugia, where he strengthened his foundation in molecular neuropathology. He further enhanced his expertise through intensive neuropathology and laboratory medicine courses in leading European scientific hubs such as Berlin, Budapest, Lübeck, Aachen, and specialized mitochondrial research programs in Schroecken, Austria. As a visiting professor at the M. Ospanov West Kazakhstan State Medical Academy, he delivered advanced lectures and supervised doctoral research in neurodegenerative and demyelinating disorders.Prof. Michalak’s scientific portfolio demonstrates exceptional breadth and innovation. He has played a central role in multidisciplinary research initiatives, including a large Polish–Singaporean project developing computer-aided decision support systems for acute ischemic stroke therapy, and joint studies with international collaborators aimed at profiling pathological proteins in skin biopsies of patients with movement disorders. His work also encompasses biochemical and clinical signature identification for interferon therapy response in multiple sclerosis. As a contributor to the European COST Action project on mitochondrial mapping, he has examined the complex interplay of evolution, age, gender, lifestyle, and environmental factors on mitochondrial dynamics. His ongoing clinical research includes a major investigation on the influence of Cerebrolysin on blood–brain barrier integrity in acute ischemic stroke. He also collaborates with global experts on smart digital therapeutics using generative artificial intelligence and contributes to the Glioblastoma Research Group at Poznan University of Medical Sciences to advance biomarker-based early detection strategies.With more than five hundred scientific publications, a substantial cumulative impact factor, over two thousand citations, and a strong h-index, Prof. Michalak has established himself as a leading figure in contemporary neurology. His book publications, extensive consultancy roles, and active involvement in translational industry–academia partnerships further highlight his enduring impact. His research in stroke biology, neuroimmunology, neuro-oncology, and molecular biomarkers continues to shape clinical understanding and inspire innovation across the global neuroscience community.

Profile: Google Scholar

Featured Publications

Ambrosius, W., Michalak, S., & Kozubski, W., & Kalinowska, A. (n.d.). Myelin oligodendrocyte glycoprotein antibody-associated disease: Current insights into the disease pathophysiology, diagnosis and management. International Journal of Molecular Sciences, 22(1), 100.

Kazmierski, N. W. R., Michalak, S., & Wencel-Warot, A. (n.d.). Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology, 79, 160.

Jasiak-Zatonska, M., Kalinowska-Łyszczarz, A., Michalak, S., & Kozubski, W. (n.d.). The immunology of neuromyelitis optica—Current knowledge, clinical implications, controversies and future perspectives. International Journal of Molecular Sciences, 17(3), 273.

Wyciszkiewicz, A., Kalinowska-Łyszczarz, A., Nowakowski, B., Kaźmierczak, K., & Michalak, S. (n.d.). Expression of small heat shock proteins in exosomes from patients with gynecologic cancers. Scientific Reports, 9(1), 9817.

Zaborowski, M. S., Spaczynski, M., & Nowak-Markwitz, E., & Michalak, S. (n.d.). Paraneoplastic neurological syndromes associated with ovarian tumors. Journal of Cancer Research and Clinical Oncology, 71.

Adamczak-Ratajczak, A., Kupsz, J., Owecki, M., Zielonka, D., Sowinska, A., & Michalak, S., et al. (n.d.). Circadian rhythms of melatonin and cortisol in manifest Huntington’s disease and in acute cortical ischemic stroke. Journal of Physiology and Pharmacology, 68(4), 539–546.

Song Chian | Neuropharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Song Chian | Neuropharmacology | Best Researcher Award

Professor at Zhejiang police college | China

Prof. Song Chian is the Director of the Forensic Physical and Chemical Teaching and Research Section at the Criminal Science and Technology College of Zhejiang Police College. With a specialized focus in drug toxicology, Prof. Song has significantly contributed to forensic science education and research. Over the past five years, he has led and participated in multiple national and provincial research initiatives, producing over 20 academic publications. His work explores the mechanisms of drug addiction and its implications in forensic toxicology. Prof. Song remains a key academic leader, mentoring future forensic professionals and contributing to policy and practical advancements in the field.

Publication Profile  

Scopus

Education 

Prof. Song Chian received his academic training in forensic science and toxicology, laying a strong foundation for his specialized work in forensic drug analysis. He completed his undergraduate and graduate studies in criminal science and technology, followed by advanced training in toxicology with a focus on the physiological and biochemical mechanisms of drug addiction. Throughout his academic career, he has actively participated in continuing education programs, academic workshops, and research methodology training both nationally and provincially. His education has equipped him with the knowledge and analytical skills essential for high-level research and teaching in forensic toxicology.

Experience 

Prof. Song Chian currently serves as Director of the Forensic Physical and Chemical Teaching and Research Section at Zhejiang Police College. Over the years, he has accumulated extensive experience in forensic toxicology, both in academia and applied research. He has served as Principal Investigator for projects funded by the Zhejiang Provincial Basic Public Welfare Research Program and has collaborated on major national initiatives. His expertise spans forensic drug detection, mechanisms of addiction, and analytical techniques in toxicology. In his academic role, he has mentored students, developed specialized curricula, and published widely in the field, shaping the next generation of forensic scientists.

Awards and Honors 

Prof. Song Chian has been recognized for his contributions to forensic science research and education. Although specific awards are not listed, his leadership roles and funding successes—such as being Principal Investigator for major research projects funded by the Zhejiang Provincial Basic Public Welfare Research Program—demonstrate academic and professional recognition. His selection to contribute to national-level special projects and National Natural Science Foundation initiatives further reflects his credibility and standing in the research community. His continuous publication record and position as director within Zhejiang Police College indicate high-level institutional trust and respect within the field of forensic toxicology.

Research Focus 

Prof. Song Chian’s primary research focus lies in the toxicology of drugs, with a particular emphasis on the mechanisms of drug addiction. His work aims to uncover the physiological and chemical pathways that underpin addictive behaviors and drug-induced toxicity. By integrating forensic science with pharmacology, Prof. Song’s research supports both legal investigations and public health policies. His approach combines analytical chemistry techniques with behavioral science models to understand drug interactions in the human body. Through his projects and academic publications, he contributes to improved drug detection methods, toxicological risk assessment, and the development of prevention strategies for substance abuse.

Publication Top Notes

  • Fentanyl Induces Novel Conditioned Place Preference in Adult Zebrafish, Disrupts Neurotransmitter Homeostasis, and Triggers Behavioral Changes

yang huanzhi | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

yang huanzhi | Pharmacology | Best Researcher Award

Dr. yang huanzhi, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China, China

Dr. Huanzhi Yang is a Ph.D. candidate in Food Science and Engineering at China Agricultural University (2019–2025) 🎓, focusing on food nutrition, natural products, and chronic disease prevention. With a strong academic background from Hunan Agricultural University and Huaihua University, his research spans functional food development, gut health, and antioxidants. He has authored multiple high-impact publications 📝, holds several international patents 🧪, and has collaborated on national food science projects. Recognized for his innovation and excellence, Dr. Yang has received numerous scholarships, awards, and honors 🏆, showcasing his commitment to scientific advancement and food health solutions.

Publication Profile

Scopus

Education

Dr. Yang Huanzhi 🎓 is currently pursuing a Ph.D. in Engineering at China Agricultural University (2019.09–2025.06), specializing in Food Science and Engineering under the guidance of Prof. Xiaojun Liao 🍎. He earned his Master’s degree in Bioengineering from Hunan Agricultural University (2016.09–2018.06), mentored by Prof. Guoping Peng 🧬. Dr. Yang began his academic journey at Huaihua University, where he completed his Bachelor’s degree in Bioengineering (2012.09–2016.06) 📘. With a solid foundation in food and biosciences, his research focuses on advancing food science and nutritional engineering for a healthier future 🌱.

Experience

Dr. Yang Huanzhi’s research focuses on food nutrition and health 🍽️, emphasizing the role of natural products in preventing and controlling chronic diseases 💊. With a passion for improving public well-being, he explores the bioactive components in natural sources 🌿 and their potential in promoting long-term health. His work contributes to the development of functional foods that not only nourish but also serve therapeutic purposes 🥦. By integrating nutritional science with innovative food engineering, Dr. Yang aims to create sustainable, health-promoting dietary solutions for modern lifestyles 🧠❤️. His dedication is shaping the future of preventive nutrition and wellness.

Awards

Dr. Yang Huanzhi has been recognized for his outstanding academic and research achievements 🌟. From 2020 to 2024, he consistently received the “Second Class Scholarship” 🏅 for five consecutive years during his doctoral studies at China Agricultural University. In 2022, he earned the second prize in the 3rd “Xingnong Cup” Innovation and Entrepreneurship Competition 💡. His dedication to safety and responsibility earned him the honorary title of Excellent Laboratory Safety Officer for two consecutive years (2021–2022) 🧪🛡️. Additionally, in 2019, his master’s work was honored with the “Excellent Master’s Thesis” award from Hunan Agricultural University 📜🏆.

Research Focus

Dr. Yang Huanzhi focuses on nutraceuticals, gut microbiota, and inflammation-related diseases. His research delves into how natural plant-based compounds—particularly polyphenols from CiLi (Rosa roxburghii Tratt.)—can modulate the gut microbiota-lipid mediator-immunity axis to alleviate chronic inflammatory conditions such as colitis. 🌿 His work bridges phytochemistry, immunology, and microbiome research, emphasizing the therapeutic potential of functional foods and dietary interventions. 🧫💊 By uncovering the molecular pathways through which CiLi polyphenols influence gut health and immune regulation, Dr. Huanzhi contributes to the advancement of integrative medicine and functional nutrition in disease prevention and treatment.

Publication Top Notes

CiLi (Rosa roxburghii Tratt.) polyphenols improve colitis via gut microbiota-lipid mediator-immunity axis

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Assoc Prof Dr Isabel Cristina Céspedes, Escola Paulista de Medicina – UNIFESP, Brazil

Assoc. Prof. Dr. Isabel Cristina Céspedes is a prominent researcher with a focus on genetics, neuroscience, and psychobiology. She obtained her Ph.D. in Morphofunctional Sciences from the University of São Paulo in 2007, specializing in stress-related brain responses in rodents. With postdoctoral work at UNIFESP and extensive teaching experience at universities like USP and UNIP, she explores topics such as substance abuse, epigenetics, and transfusion medicine. She has contributed to numerous publications in journals like Behavioural Brain Research and The Journal of Neuroscience. Her ongoing research investigates the effects of blood transfusions and addiction disorders. 🧠🔬💉📚

Publication Profile

Google Scholar

Educational Background

Assoc. Prof. Dr. Isabel Cristina Céspedes has a distinguished academic background, holding a Ph.D. in Morphofunctional Sciences from the University of São Paulo, specializing in neurobiological responses to stress 🧠. Her postdoctoral research at the Federal University of São Paulo deepened her expertise in genetic and molecular neurobiology 🔬. With a passion for understanding the intricate mechanisms of stress at the molecular level, Dr. Céspedes has contributed significantly to the field, advancing knowledge in neurobiology and stress-related disorders. Her work continues to inspire and shape research in neuroscience and molecular biology 🧬✨.

Leadership in Academia

Dr. Céspedes is an active educator, researcher, and mentor at prestigious institutions such as UNIFESP and USP, where she has made significant contributions to the academic community 📚. With her dedication to higher education, she holds several administrative and leadership roles, guiding academic programs and playing a pivotal part in various committees 🏫💼. Her work reflects a passion for both academic excellence and student mentorship, and her leadership has helped shape the educational landscape at these esteemed institutions 🌟. Through her efforts, Dr. Céspedes continues to inspire and shape future scholars and professionals 🌱.

Research Projects

Dr. Céspedes is conducting pioneering research on the epigenetic effects of blood transfusions, aiming to enhance clinical practices and improve patient outcomes. By examining how transfusions influence gene expression, their work is providing valuable insights into patient health and long-term recovery. Dr. Céspedes’ research contributes to a deeper understanding of the molecular mechanisms involved, which could lead to more personalized medical treatments and better management of transfusion-related complications. This groundbreaking work is opening new avenues in both clinical and genetic research, offering potential advancements in healthcare. 🧬🩸🔬👩‍🔬

Research Focus

Dr. Isabel Cristina Céspedes focuses on neuroscience, particularly in the areas of neuroplasticity, anxiety, stress responses, and neurogenesis. Her research investigates how environmental factors, such as chronic stress and psychological interventions, affect the brain’s defensive responses, Fos immunoreactivity, and hippocampal neurogenesis. She has also explored the effects of substances like alcohol on brain function, including how they alter locomotion and neurocircuitry associated with reward and anxiety. Additionally, Dr. Céspedes contributes to studies on hormonal regulation, particularly cortisol, and its implications for mental health. Her work spans animal models, psychological interventions, and neurobiological mechanisms. 🧠🔬💉📚

Publication Top Notes

Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis

Physical therapy and psychological intervention normalize cortisol levels and improve vitality in women with endometriosis

Una alternativa natural para el tratamiento de la COVID-19

Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis

Environmental enrichment decreases avoidance responses in the elevated T-maze and delta FosB immunoreactivity in anxiety-related brain regions

The Edinger–Westphal nucleus II: Hypothalamic afferents in the rat

Acute restraint differently alters defensive responses and fos immunoreactivity in the rat brain

mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration

Alcohol consumption increases locomotion in an open field and induces Fos-immunoreactivity in reward and approach/withdrawal-related neurocircuitries